BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnology industry.. More information on NORTHERN , seeUpcoming BIO EventsBIO-Asia Partnering Conference Jan. 28 to 29, 2008 Tokyo, JapanNew BIO CEO & Investor Conference from 11 bis 13 February 2008 York, NYPartnering for Global Health 10 to 12 March 2008 Washington, DCBIO-Europe Spring April 7-9, 2008 Madrid, SpainWorld Congress on Industrial Biotechnology & Bioprocessing April 27-30, 2008 Chicago, ILBIO International Convention June 17 to 20 in San Diego, CAAbout BIOBIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other countries.
The law has to live to a great increase in the number of therapies available to the more than 25 million Americans out with the 7,000 recognized rare diseases and significantly contributed to the growth of the biotechnology industry. – the biotech industry has taken in the past to develop treatments and to develop treatments and cures to serve small patient populations with rare, devastating illness. The Orphan Drug Act established some necessary protection, Food & Drug Administration the necessary investments for research and development of breakthrough technology ..The solution of can however be rooted in an unconventional therapeutic starting.
Last year a team from thinking David Eidelberg, head of the Feinstein Institute centers for Neuroscience introduced out, canceled of these mutation carrier is protected symptoms persist – they have an additional lesion similar the score. In in the Journal of Neuroscience has been described team two separate areas of brain taken along path that. Cerebellum links to the motor cortex of The integrity of the way in these two regions together, if a mutation beam will be show clinical manifestations of the sickness.
Normally, the cerebellum breaks in the motor cortex by potentiating retardation in to the cortical level The is likely to a mutation substrate development problems in the currents of neural signals of. Signals Start of this circuit that the brain is no are inhibiting undesirable movement By second passage lesion, said Dr. Eidelberg, the flow rate turned off and the an abnormal activity stops. .